Oreja-Guevara C, Gonzalez-Suarez I, Eichau Madueño S, Otero Romero S, Calvo Díez M, Engroba Teijeiro C, Casado Gómez A, Castro Albarrán P, Meca-Lallana J
Phenotype distribution and differential disease burden in multiple sclerosis: real-world data from The Apolo Study
12th Congress of the European Academy of Neurology. Viena. 27-30 jun 2026
Espinoza-Cámac N, Gómez-Barrera M, Oyagüez I, Badia-Tahull M, Calleja M, Martín Martínez J, Martínez Yélamos S, Prieto González J, González A, Saccardo P, Bernardo B, Sainz de los Terreros A, Gadea J
Cost-minimisation analysis of natalizumab biosimilar compared to reference natalizumab for multiple sclerosis
10th European Academy of Neurology (EAN) Congress. Helsinki (Finlandia). 29 jun-02 jul 2024
Espinoza N, Salinas L, Oyagüez I, Gómez Maldonado L
Cost-analysis of the tolerability, adherence and persistence to treatment of diroximel fumarate versus dimethyl fumarate
9th European Academy of Neurology (EAN) Congress. Budapest. 1-4 jul 2023
Alonso Torres AM, Arévalo Bernabé AG, Becerril Ríos N, Hellín Gil MF, Martínez Sesmero JM, Meca Lallana V, Ramió-Torrentá L, Rodríguez-Antigüedad A, Gómez Maldonado L, Gómez-Barrera M, Espinoza N, Oyagüez I